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Background: TliA is a thermostable lipase secreted by the type 1 secretion system (T1SS) of Pseudomonas
fluorescens. The secretion is promoted by its secretion/chaperone domain located near the C-terminus, which is
composed mainly of four Repeat-in-Toxin (RTX) repeats. In order to identify the minimal region of TliA responsible
for its secretion, five different copies of the secretion/chaperone domain, each involving truncated N-terminal
residues and a common C-terminus, were acquired and named as lipase ABC transporter recognition domains
(LARDs). Each LARD was fused to epidermal growth factor (EGF) or green fluorescent protein (GFP), and the
secretion of EGF-LARD or GFP-LARD fusion proteins was assessed in Escherichia coli with ABC transporter.
Results: Among the fusion proteins, GFP or EGF with 105-residue LARD3 was most efficiently secreted. In addition,
GFP-LARD3 emitted wild type GFP fluorescence. Structurally, LARD3 had the 4 RTX repeats exposed at the
N-terminus, while other LARDs had additional residues prior to them or missed some of the RTX repeats. LARD3
was both necessary and sufficient for efficient secretion and maintenance of GFP fluorescence in E. coli, which was
also confirmed in P. fluorescens and P. fluorescens △tliA, a knock-out mutant of tliA.
Conclusion: LARD3 was a potent secretion signal in T1SS for its fusion flanking RTX motif, which enhanced
secretion and preserved the fluorescence of GFP. LARD3-mediated secretion in E. coli or P. fluorescens will enable
the development of enhanced protein manufacturing factory and recombinant microbe secreting protein of
interest in situ.
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The type 1 secretion system (T1SS) secretes polypeptides
to the extracellular medium in gram-negative bacteria [1].
T1SS is composed mainly of ATP-binding cassette (ABC)
transporter, which is comprised of ABC protein [2], adaptor
or membrane fusion protein (MFP) [3], and outer mem-
brane protein (OMP) [4]. The ABC protein captures the
substrate polypeptide and transports it through the* Correspondence: hoony@kaist.ac.kr
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reproduction in any medium, provided the orcontiguous channel formed by MFP and OMP by coupling
ATP hydrolysis [5-7]. The MFP-OMP channel penetrates
both gram-negative membranes simultaneously, leaving no
periplasmic intermediates [8]. T1SS is also referred to as a
signal peptide-independent secretion system because the
secretion is mediated by the C-terminal region of a sub-
strate polypeptide instead of the signal sequence [9].
TliA is a 476 aa thermostable lipase encoded in the lipase
operon of Pseudomonas fluorescens. TliA is secreted by a
dedicated T1SS composed of TliDEF, an ABC transporter
encoded in the upstream of TliA within the lipase operon
[10]. TliA is exported by TliDEF in high efficiency at 25°C,
which is the optimum growth temperature of P. fluorescens. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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ABC transporter of Erwinia chrysanthemi, at 37°C [11].
TliA has a lipase activity domain, a hinge region, a secre-
tion/chaperone domain, and a calcium-binding domain
(4 RTX repeats) in residues 1–268, 269–278, 279–476, and
373–417, respectively [11].
Several T1SS substrate polypeptides have been widely
studied. Those include HlyA from Escherichia coli
[12,13], PrtB and PrtC from E. chrysanthemi [14,15],
AprAPA from Pseudomonas aeruginosa [16], and TliA
from P. fluorescens [10]. These substrate polypeptides
share common structures such as an extreme C-
terminal motif [17], a hydrophobic five-residue sequence
motif (VTLIG) [18,19] and a Repeat-in-Toxin (RTX)
motif, GGxGxDxUx repeats (x: any amino acids; U: large
hydrophobic residues such as L, I, or F). According to
the crystal structures of AprAPA [20,21] and PrtASM
[22,23], the RTX motif forms a β-roll structure in which
two RTX repeats constitute a complete turn involving a
short parallel β-sheet. The RTX motif has also been re-
ferred to as a calcium-binding domain [9,16,24,25], be-
cause Ca2+ ions are required for the stabilization of the
β-roll structure [26]. The exact role of the RTX motif
has not been pinpointed, but it is known to affect recep-
tor binding [27], enhance secretion [28], act as an in-
ternal chaperone [21], and increase protein levels in the
cytoplasm [29]. T1SS substrate polypeptides have no
strictly-defined residues required for secretion, but the
overall structure including the RTX motif determines
the secretion.
In this research, the minimal region in TliA responsible
for its secretion was investigated. Five different copies of
the secretion/chaperone domain, the C-terminal region of
TliA involving the RTX motif, were obtained. These differ-
ent lengths of polypeptides, defined as the lipase ABC
transporter recognition domain (LARD), were attached to
the C-terminus of epidermal growth factor (EGF) or green
fluorescent protein (GFP). The fusion proteins were
expressed with appropriate T1SS in E. coli, P. fluorescens,
and P. fluorescens ΔtliA, a knock-out mutant lacking tliA
in its genome. As a result, LARD3 was necessary and suffi-
cient for efficient secretion. In addition, several observa-
tions suggested the RTX motif as both a secretion
enhancer and an internal chaperone.
Results
Construction of GFP-LARD and EGF-LARD fusion proteins
LARD1 to 5 were constructed by PCR amplifying the se-
cretion/chaperone domain of TliA from residues 303,
337, 373, 407, and 442 to the C-terminus (residue 476),
respectively. The features of the secretion/chaperone do-
main and LARDs are shown (Figure 1A). LARDs were
fused to the C-terminus of GFP to construct GFP-LARD
fusion proteins with a Factor Xa protease cleavage siteas a linker. EGF-fusion proteins were constructed in a
similar manner as GFP-fusion proteins. The three-
dimensional structures of LARDs predicted by SWISS-
MODEL structural modeling program [30] are also
represented (Figure 1B). LARD1 (174 aa) included 70
additional residues prior to the 4 RTX repeats. Those
residues were partly removed in LARD2 (140 aa) and
completely removed in LARD3 (104 aa). As a result, the
RTX motif was exposed at the N-terminus of LARD3.
Three out of 4 RTX repeats were removed in LARD4
(70 aa), and LARD5 (35 aa) was deprived of any com-
mon structures except for the extreme C-terminal motif.
Expression and secretion of EGF-LARDs in E. coli
The expression and secretion of EGF-LARD1 to 5 and
EGF-TliA were examined in E. coli XL1-Blue with or
without PrtDEF, the ABC transporter of E. chrysanthemi.
The expression of EGF-fusion proteins, as analyzed by
western blotting, was heterogeneous (Figure 2). EGF-
LARD3 was undetected in the cell when it was co-
expressed with PrtDEF. However, it was detected inside
the cell when PrtDEF was absent. The same result was
also observed in E. coli MM294. Because it is close to
the original strain E. coli K12 [31], exhibiting wild-type
phenotype, and showed strong fluorescence when trans-
formed with GFP gene in our experiment, E. coli
MM294 was used together with XL1-Blue throughout
the experiments. However, we do not draw any conclu-
sion by contrasting the results obtained from the two
strains as our purpose in this research is to draw a
generalization that applies to a wide range of species.
For extracellular secretion, EGF-LARD3, EGF-LARD4
and EGF-TliA were secreted from E. coli XL1-Blue
(Figure 3A) while only EGF-LARD3 was secreted from
E. coli MM294 (Figure 3B). Since EGF-LARD3 was
detected only in the extracellular medium when the cells
co-expressed PrtDEF, and was detected solely in the
cytoplasm when the cells did not express PrtDEF, it was
evident that secretion occurred through the ABC trans-
porter instead of other possible pathways such as cell
rupture. The concentration of the secreted EGF-LARD3
was about 3.3 μg/ml as determined by comparing to the
purified lipase solution.
Expression and secretion of GFP-LARDs in E. coli
The intracellular expression of GFP-LARDs in E. coli
was analyzed by western blotting (Figure 4). GFP-
LARDs and GFP-TliA were uniformly expressed by E.
coli cells harboring pGFP-LARD1 to 5 or pGFP-TliA,
each with pEcPrtDEF (the vector harboring prtDEF).
The secretion pattern of different GFP-LARD fusion
proteins was analyzed in E. coli XL1-Blue (Figure 5A)
and E. coli MM294 (Figure 5B). In contrast to EGF, GFP
was secreted by many types of LARDs except for
Figure 1 The features and structures of LARDs. A. The secretion/chaperone domain of TliA (residues 301–476). The residues and PCR
amplification sites of LARDs are also shown overlapped. TliA has a calcium-binding domain (373–416) comprised of four GGxGxDxUx repeats,
hydrophobic five-sequence motif and an extreme C-terminal motif, EGVLIS. The three-dimensional structures of each LARDs were predicted by
SWISS-MODEL structural modeling according to their residues and displayed by UCSF Chimera (http://www.cgl.ucsf.edu/chimera/) [30]. The RTX
motif is indicated by the arrowhead. B. TliA, C-G. LARD1 to 5. Note that LARD3 has the RTX motif exposed at the N-terminus. The protein data
bank (PDB) IDs for the templates used to predict each structure are as follows: TliA, 2z8z_A; LARD1, 2z8z_A; LARD2, 2qub_A; LARD3, 2zvd_C;
LARD4, 2qub_A; LARD5; 2zvd_C.
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Figure 2 The intracellular expression of EGF-LARDs in E. coli XL1-Blue. Each E. coli XL1-Blue culture harboring one of pEGF-LARD1-4 (lanes
1–4) or pEGF-TliA (lane A) with pEcPrtDEF (+) or pACYC-184 (−) was incubated with 0.05 mM IPTG, 50 μg/ml ampicillin, and 34 μg/ml
chloramphenicol in 2 ml glass tubes at 37°C. The cells were isolated from the extracellular medium by double centrifugation, underwent
SDS-PAGE in 15% gel, and analyzed by western blotting using anti-LARD antibodies. The plasmid pACYC-184 was used as a negative control for
pEcPrtDEF which encodes PrtDEF. Purified TliA at a concentration of 99 μg/ml was used as an index after dilution. The arrowheads indicate the
size of each EGF-LARD.
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showed the greatest concentration in the extracellular
medium. This pattern was more evident in E. coli
MM294 than in XL1-Blue, the concentration of GFP-
LARD3 in the former being approximately 10 μg/ml.
The GFP fluorescence of different GFP-LARD fusion
proteins was analyzed under UV light (Figure 6A) and
quantitatively measured by fluorescence spectroscopy
(Figure 6B). At 25°C which is the optimum growth
temperature of P. fluorescens, the host species of TliA
from which LARDs are derived, GFP-LARD3 showed the
highest fluorescence in both E. coli XL1-Blue andFigure 3 The extracellular secretion of EGF-LARDs in E. coli XL1-Blue
culture harboring one of pEGF-LARD1-4 (lanes 1–4) or pEGF-TliA (lane A) w
collected. The growth conditions were identical to those in Figure 2. SDS-P
were performed on the supernatant. The (+) sign indicates the presence o
used as a negative control). Purified TliA at 99 μg/ml concentration was us
MM294. The methods used here were identical to those used in (A).MM294, exhibiting 96% that of the wild type GFP in
MM294. As the temperature increased from 25°C to 37°C,
the fluorescence decreased for GFP-LARD3. Other GFP-
LARD fusion proteins showed a similar decrease in fluor-
escence in E. coli XL1-Blueand MM294.
Further analyses on the expression and secretion of
GFP-LARDs in P. fluorescens were undertaken with
GFP-LARD3 and GFP-TliA which were suitable for de-
tection in the western blotting and lipase activity plate,
respectively. The GFP-TliA was detected easily on the
tributyrin plate when it was secreted by ABC trans-
porter, showing halos around colonies.and MM294. A. The secretion of EGF-LARDs in E. coli XL1-Blue. Each
ith pEcPrtDEF was centrifuged twice, and the supernatant was
AGE with 15% gel and western blotting with anti-LARD antibodies
f PrtDEF. The (−) sign indicates the absence of PrtDEF (pACYC-184 was
ed as an index after dilution. B. The secretion of EGF-LARDs in E. coli
Figure 4 The intracellular expression of GFP-LARDs in E. coli XL1-Blue. Each E. coli XL1-Blue culture harboring one of pGFP-LARD1-4
(lanes 1–4), pGFP-TliA (lane A) or pGFP-223 (lane None) with pEcPrtDEF (+) or pACYC-184 (−) was grown with 50 μg/ml ampicillin and 34 μg/ml
chloramphenicol in a 2 ml glass tube at 37°C (IPTG was not added). The culture was centrifuged twice, and the pellet was isolated. SDS-PAGE
with 10% gel and western blotting with anti-LARD antibodies were performed on the pellet. Purified TliA at a concentration of 99 μg/ml was
used as an index after dilution.
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fluorescens
LARDs were derived from a lipase of P. fluorescens. To
check whether GFP-LARD fusion proteins were secreted
better in the original host, the fusion proteins and an ABC
transporter were introduced into P. fluorescens. In theFigure 5 The extracellular secretion of GFP-LARDs in E. coli XL1-Blue
coli XL1-Blue culture harboring one of pGFP-LARD1-5 (lanes 1–5), pGFP-TliA
(−) was centrifuged twice, and the supernatant was collected. The growth
10% gel and western blotting with anti-LARD antibodies were performed o
used as an index after dilution. B. The secretion of GFP-LARDs in E. coli MM
signs are also identical to those of A.former experiments, the GFP-fusion proteins were
secreted in E. coli through a two-vector system in which
the coding sequences of GFP-fusion proteins were
inserted in pKK223 and that of the ABC transporter,
PrtDEF, was inserted in pACYC184. The plasmids used
for E. coli could not be used in P. fluorescens, so a broadand MM294. A. The secretion of GFP-LARDs in E. coli XL1-Blue. Each E.
(lane A) or pGFP-223 (lane None) with pEcPrtDEF (+) or pACYC-184
conditions were identical to those listed in Figure 4. SDS-PAGE with
n the supernatant. Purified TliA at a concentration of 99 μg/ml was
294. The methods used here were identical to those listed in A. The
Figure 6 The GFP fluorescence of recombinant E. coli colonies at different temperatures. A. GFP fluorescence detected on LB plates. Single
colonies of E. coli XL1-Blue and MM294, each harboring one of the designated plasmids, were streaked on LB plates and grown at 25°C or 37°C.
They were subsequently analyzed under UV light. Starting from the culture designated by the arrowhead in a clockwise direction, the plasmids
content is as follows: pGFP-223; pGFP-LARD1-5; and pGFP-TliA. B. GFP fluorescence assay. The cultures of E. coli XL1-Blue and MM294 in A were
grown in liquid LB. The cells were washed and analyzed under excitation of 485 nm and emission of 535 nm. The relative fluorescence of each
culture compared to that of the culture harboring pGFP-223 was plotted on the graph in a percentage scale (%).
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porter encoded in the lipase operon of P. fluorescens, was
inserted into pDSK-519 together with the coding
sequences of GFP-LARD3 and GFP-TliA. A similar result
obtained from E. coli (Figure 6) was also observed when P.
fluorescens cells harboring above plasmids were assayed
for GFP fluorescence (Figure 7). As expected, in P.
fluorescens, GFP-LARD3 had a comparable GFP fluores-
cence to that of an intact GFP. P. fluorescens harboring
pDX-GFP-TliA showed a low fluorescence comparable to
that of wild type P. fluorescens.
The intracellular and extracellular expressions of GFP-
LARD3 and GFP-TliA in P. fluorescens were analyzed by
western blotting using anti-LARD antibodies (Figure 8).
The P. fluorescens cells harboring pDSK-TliA, pDX-TliA,
pDX-GFP-LARD3, and pDX-GFP-TliA were grown in
LB or 2× LB media. The intracellular expression was
uniform for each protein in each growth condition. The
intrinsic TliA (encoded by the genomic tliA) was
detected in every extracellular medium, as indicated by
the arrow. Here, TliA was also secreted by the intrinsic
ABC transporter in the lipase operon of P. fluorescens
(Figure 8, lane 1). GFP-LARD3 was more efficiently
exported than GFP-TliA in P. fluorescens, as was the
case in E. coli. The secretion efficiency was generally
higher when the fusion proteins were exported by Tli-
DEF in P. fluorescens than by PrtDEF in E. coli. The in-
trinsic TliA was secreted more favorably by TliDEF in
that some fractions of GFP-LARD3 and GFP-TliA were
left inside the cells while all intrinsic TliA was found
outside the cells (Figure 8, lane 3 and 4). Furtheranalyses were undertaken with P. fluorescens ΔtliA to
eliminate the intrinsic TliA from the extracellular
medium.
Expression and secretion of GFP-LARD3 and GFP-TliA in P.
fluorescens ΔtliA
P. fluorescens ΔtliA, the genomic tliA-deficient strain,
was used to detect the intracellular expression and
extracellular secretion of GFP-LARD3 and GFP-TliA
(Figure 9). Cells harboring pDSK-TliA, pDX-TliA, pDX-
GFP-LARD3, and pDX-GFP-TliA were analyzed by west-
ern blotting. The patterns were identical to those
observed in the wild type P. fluorescens, except that the
intrinsic TliA was absent in the extracellular medium of
pDX-GFP-LARD3. GFP-LARD3 was detected inside the
cell and in the extracellular medium without TliA. How-
ever, although the genomic tliA was deleted, both TliA
and GFP-TliA were found in the extracellular medium
of the cells that expressed only GFP-TliA. When the
same intracellular and extracellular media were analyzed
using anti-GFP antibodies, GFP was found as its mono-
meric size in the extracellular medium while only the in-
tact GFP-TliA was detected inside the cell (data not
shown). It appears that GFP-TliA was degraded by pro-
teolysis after secretion. Experiments with P. fluorescens
ΔprtA, which was constructed recently in our laboratory,
showed that GFP-TliA was indeed degraded by the pro-
tease PrtA which is encoded in the lipase operon and is
also secreted by TliDEF [10]. The degradation of extra-
cellular GFP-TliA was not observed in E. coli as shown
in previous figures.
Figure 7 The GFP fluorescence of recombinant P. fluorescens colonies. The recombinant P. fluorescens cells harboring appropriate plasmids
were cultured on an LB plate, and the GFP fluorescence was analyzed using UV light. Label 1, pDSK-TliDEF-GFP-LARD3 (pDX-GFP-LARD3); label 2,
pDX-GFP-223; label 3, pDX-TliA; label 4, pDX-GFP-TliA.
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In this research, LARD has been reported to be a secre-
tion signal capable of exporting GFP or EGF through the
gram-negative T1SS. LARD1 to 5 were acquired from
the secretion/chaperone domain of TliA, and they
involved part of the homologous structures essential for
secretion, such as the RTX repeats, hydrophobic five-
residue sequence motif and an extreme C-terminal
motif. LARDs were attached to GFP or EGF, and the fu-
sion proteins were expressed in E. coli and P. fluorescens
with PrtDEF or TliDEF. The secretion was observed
with different LARD fusion proteins, among which EGF-
LARD3 and GFP-LARD3were most efficient in the se-
cretion of EGF and GFP. In addition, GFP-LARD3
retained its native GFP fluorescence, while the other fu-
sion proteins had a diminished fluorescence.
The GFP fluorescence was preserved particularly in
GFP-LARD3. Note that LARD3 had the 4 RTX repeats
exposed at the N-terminus, while others had additional
residues prior to them or missed several repeats. It
appeared that in GFP-LARD3, the RTX repeats had pre-
served GFP by structurally separating it from the
remaining residues of LARD3. It is yet uncertain
whether or not RTX repeats form a stable β-rollstructure or remain intrinsically disordered in the cyto-
sol, but in either case, they were able to preserve GFP by
acting like a structural barrier. In support of this hypoth-
esis, Blenner et al. provided evidence of the RTX motif
as a distinct domain that can be folded or unfolded inde-
pendently to the rest of the polypeptide [32]. Either as a
β-roll or as an intrinsically disordered structure, the
RTX repeats were able to separate GFP from the secre-
tion signal.
The exact secretion mechanism of T1SS is still being
researched. Relevant findings in understanding the
mechanism of T1SS include: 1) that the substrate poly-
peptides sequentially form a multi-protein complex with
the ABC protein, MFP, and OMP prior to secretion [33];
and 2) RTX repeats are intrinsically disordered in the
calcium-free cytosol and keep the substrate polypeptide
translocation-competent [32,34]. Once exported to
the calcium-rich extracellular environment, RTX re-
peats structuralize under conditions involving entropic
stabilization and become an internal chaperone. This
spontaneous calcium-induced folding in the extracellular
medium prevents the backtracking of the substrate poly-
peptide and enhances export by conferring directionality
towards the outside of the bacterium, a process known
Figure 8 The expression and secretion of the recombinant proteins in P. fluorescens. A. The intracellular expression and secretion of
GFP-TliA and GFP-LARD3 in P. fluorescens cultured in LB were detected by western blotting using anti-LARD antibodies. The P. fluorescens cells
expressing the designated proteins with (+) or without (−) TliDEF were isolated from two different extracellular media by double centrifugation.
B. The same expression was performed in 2× LB (double concentrated LB). Lane 1, pDSK-TliA; lane 2, pDX-TliA; lane 3, pDX-GFP-LARD3; lane 4,
pDX-GFP-TliA. The arrows indicate the sizes of GFP-LARD3 (38.2 kDa), TliA (49.9 kDa), and GFP-TliA (77.4 kDa). Notice the intrinsic TliA indicated by
the arrows.
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that there are complex intermediate protein-protein
interactions involved in secretion. The fundamental
source of these complications is the C-terminal
localization of the secretion signal; a complete transla-
tion is required prior to secretion. Since the exportFigure 9 The expression and secretion of the recombinant proteins in
GFP-TliA and GFP-LARD3 were analyzed by western blotting using anti-LAR
double centrifugation. Lane 1, pDSK-TliA; lane 2, pDX-TliA; lane 3, pDX-GFP
LARD3 (38.2 kDa), TliA (49.9 kDa), and GFP-TliA (77.4 kDa).passage is too narrow for a folded globular protein to
pass, there must be some mechanism that retains the
synthesized substrate polypeptide relatively unfolded and
translocation-competent [35].
There is a paradox, in that GFP-LARD3 had a native
fluorescence while being most efficiently secreted. TheP. fluorescens ΔtliA. The intracellular expression and secretion of
D antibodies. The cells were isolated from the growth medium by
-LARD3; lane 4, pDX-GFP-TliA. The arrows indicate the sizes of GFP-
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the high secretion efficiency indicates the intrinsically-
disordered, relatively unfolded, translocation-competent
state of the fusion protein [36]. The more compactly the
GFP was folded, the harder it become for the fusion pro-
tein to pass through the MFP-OMP channel, decreasing
the secretion efficiency. This seeming contradiction im-
plied a more complex state of the substrate polypeptide
during secretion, such as being locally folded at the fused
domain (GFP in this case) and unfolded at the secretion
signals. Also, upon binding extracellular Ca+2 ions, the
secreted GFP-LARD fusion proteins would probably as-
sume folded C-terminal regions, but the folding of the
GFP in the extracellular medium is uncertain because only
low fluorescence was detected in the extracellular
medium. In the case of EGF, EGF-LARD3 shows normal
EGF function after secretion [37]. The structure and func-
tion of secreted proteins were not sure but the proteins
were assumed to be folded after the secretion but possibly
failed to fold into normal structure.
Conclusions
The RTX motif directly linked with fusion protein
enhanced secretion and preserved the fluorescence of GFP.
The 4 RTX repeats in TliA were not strictly required for se-
cretion as LARD4, which is deficient of 2 out of 4 RTX
repeats, was still secreted. However, as LARD3 showed, the
secretion was most efficient in the presence of all 4 RTX
repeats without any additional N-terminal residues. LARD3
was a minimal region in TliA capable of exporting GFP
and maintaining its fluorescence. LARD3 was recently used
to make a transgenic probiotic microbe secreting EGF for
enhanced would healing [37]. LARD3 presents a suitable
tool to produce useful recombinant proteins extracellularly
in E. coli or in P. fluorescens, and even more, to design an
in situ protein manufacturing factory utilizing living
microbes in producing and secreting proteins of interest.
Methods
Bacterial strains and plasmids
E. coli XL1-Blue, E. coli MM294, and P. fluorescens SIK
W1 (KCTC 7689) were used as hosts for DNA manipu-
lation and gene expression. E. coli MM294 (F– endA1
hsdR17 (rK
–mK
+) glnV44 thi-1 relA1 rfbD1 spoT1) was
used as expression host because GFP was expressed well
to show strong fluorescence. This strain is very close to
wild type E. coli K-12 [31]. P. fluorescens SIK W1 ΔtliA,
a knock-out mutant lacking the genomic TliA, was con-
structed in the authors’ laboratory. Plasmids pKK223-3,
pDSK-519, and pACYC-184 were used as expression
vectors. The plasmids were introduced into E. coli cells
by heat transformation and into P. fluorescens cells by
electroporation or conjugation using E. coli F-positive
strain S17-1 as a donor.Expression of fusion proteins
E. coli was grown in Luria-Bertani (LB) at 37°C for one
day in an orbital shaker at 150 rpm. For the expression
of fusion proteins, E. coli was grown in 2 ml medium in
a 15 ml culture tube. Isopropyl β-D-1-thiogalactopyra-
noside (IPTG) was added at 0.05 mM for the expression
of pKK223-3-derived plasmids which is under tac pro-
moter. For dual plasmid expression, 50 μg/ml ampicillin
was used to maintain the plasmids derived from
pKK223-3, and 34 μg/ml chloramphenicol was used to
maintain the pACYC-184 derivatives. P. fluorescens was
grown in LB or 2× LB media at 25°C for 2 days. The 2×
LB medium is a doubly concentrated LB medium used
for specific growth of P. fluorescens. P. fluorescens was
grown in 8 ml medium in a 20 ml glass tube at 150 rpm
to reduce the degradation of proteins by aeration [38].
pDSK519-derived plasmids were under lac promoter but
IPTG was not used because expression of genes was
constitutive in P. fluorescens [38]. For one vector system
in P. fluorescens, 30 μg/ml kanamycin was used to main-
tain the pDSK-519 derivatives.
Plasmid construction
The plasmids used in this research are summarized in
Table 1. The GFP gene from pGFPuv (Clontech, Mountain
View, CA) and LARD coding sequences from pTOTAL
were PCR amplified using primers with EcoRI/XbaI and
XbaI/HindIII sites, respectively. Factor Xa protease cleavage
site (IEGR) was added between the GFP and LARDs as a
linker by attaching the corresponding oligonucleotide to
the primers. The GFP and LARD sequences were inserted
respectively into EcoRI-XbaI and XbaI-HindIII sites of
pKK223-3 downstream of the tac promoter to construct
pGFP-LARD1 to 5. The EGF gene was PCR-amplified
using EGF-containing plasmid pGEM-hEGF and EGF-
fusion proteins were constructed in a similar manner as
GFP-fusion proteins. The prtDEF gene from Erwinia
chrysanthemi was inserted into SacI-NdeI site of pACYC-
184 to construct pEcPrtDEF. Those plasmids were intro-
duced simultaneously into E. coli XL1-Blue or MM294 via
heat transformation. The tliA and tliDEF genes were
inserted into pDSK-519 under the lac promoter to con-
struct pDSK-TliA and pDSK-TliDEF (abbreviated as pDX
throughout this paper), respectively. In addition, the coding
sequences for GFP, TliA, GFP-LARD3, and GFP-TliA were
inserted into KpnI-SacI site of pDX downstream of the
tliDEF to construct pDX-GFP-223, pDX-TliA, pDX-GFP-
LARD3, and pDX-GFP-TliA, respectively. Those plasmids
were introduced into E. coli S17-1 cells by heat transform-
ation prior to conjugation.
LARD design
TliA has a lipase activity domain in residues 1–268,
a hinge region in residues 269–278, a secretion/
Table 1 The plasmids used in this research
Plasmids Characteristics Reference
pKK223-3 Cloning vector, Apr Amersham
pACYC-184 Cloning vector, Cmr New England
Biolabs
pDSK-519 Cloning vector, Kmr [39]
pGFPuv gfp Clontech
pTOTAL P. fluorescens tliA operon [10]
pGFP-TliA gfp-tliA in pKK223-3 This study
pGFP-LARD1 to 5 gfp-lard1 to 5 in pKK223-3 This study
pEGF-LARD1 to 5 egf-lard1 to 5 in pKK223-3
pEcPrtDEF prtDEF in pACYC-184 This study
pDSK-TliA tliA in pDSK-519 This study
pDSK-TliDEF (pDX) tliDEF in pDSK-519 This study
pDX-GFP-223 gfp and tliDEF in pDSK-519 This study
pDX-TliA tliA and tliDEF in pDSK-519 This study
pDX-GFP-TliA gfp-tliA and tliDEF in pDSK-519 This study
pDX-GFP-LARD3 gfp-lard3 and tliDEF in pDSK-519 This study
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calcium-binding domain in residues 373–417 [11].
The location of PCR amplification sites for the de-
sign of LARDs was determined according to the
three-dimensional structure of TliA predicted by the
SWISS-MODEL structural modeling program at
http://swissmodel.expasy.org/ [30]. Appropriate PCR
primers were constructed to acquire five different
LARDs each elongating from residues 303, 337, 373,
407, and 442 to the C-terminus. The oligonucleo-
tides for the Factor Xa protease cleavage site were
added to the primers, and the primers were used to
fuse the LARDs to the C-terminus of GFP by means
of ligation to construct GFP-LARD fusion proteins.SDS-PAGE and western blotting
Cells were grown in the growth conditions described
in the Bacterial strains, plasmids, and growth condi-
tions section until they reached the stationary phase,
which took approximately 24 hours for E. coli and
48 hours for P. fluorescens. The cultures were sepa-
rated into pellets and supernatants by double centri-
fugation from which the expression and secretion of
the GFP-LARD fusion proteins were analyzed separ-
ately. Gel electrophoresis was undertaken according
to Laemmli [40]. Fifteen micro-liters of cell extract
or supernatant, equivalent to 15 μl OD600 ~ 2.5 cul-
ture broth (0.0375 OD600 equivalent), was loaded on
10% (v/v) SDS-PAGE, and western blotting was per-
formed as described previously [11], using anti-
LARD or anti-GFP primary antibodies. The purified
TliA (99 μg/ml) was diluted to 3.3 or 1.4 μg/ml and
used as the internal standard for western blotting.Estimation of GFP fluorescence
E. coli cells harboring pGFP-223, pGFP-LARD1 to 5, or
pGFP-TliA was grown in 3 ml LB (50 μg/ml ampicillin) at37°C for 18 hr or at 25°C for 36 hr. Different amounts of
each culture were centrifuged, washed, and resuspended
to meet OD600 =2. One hundred microliters of the re-
suspended culture was added to Greiner 96 well FluotracTM
for fluorescence measurement. Fluorescence was estimated
with excitation at 485 nm and emission at 535 using a
Tecan Genios Pro multifunction microplate reader. The
relative fluorescence of each culture was obtained by com-
paring to that of the culture harboring pGFP-223. E. coli
cells expressing different GFP fusion proteins were streaked
on an LB plate, grown for 1 or 2 days, and photographed
under long-wavelength UV light.
Construction of the P. fluorescens knock-out mutant, ΔtliA
P. fluorescens SIK W1 ΔtliA was constructed using sacB, a
levansucrase-encoding gene from Bacillus subtilis, as a se-
lection marker. Levansucrase catalyzes levan synthesis
through transfructorylation of sucrose [41] and confers le-
thality to a variety of gram-negative bacteria [42]. The tliA
gene was PCR amplified from pTOTAL and inserted into
BamHI/HindIII site of pK18mobsacB, a vector with sacB,
KmR, and a mob factor [43]. The plasmid was digested by
XhoI and SalI, which were in the middle of tliA, and ligated
to make an internal 512 bp-deficient mutant of tliA, ΔtliA.
A constructed vector pKtliAXS with ΔtliA was transferred
from E. coli S17-1 to P. fluorescens SIK W1 by conjugation
using the mob factor. Since the replication origin of
pK18mobsacB is inactive in P. fluorescens [43], the recom-
binant P. fluorescens was cultured with kanamycin and
sought for the resistant strains with pKtliAXS inserted into
the genome. That mutant strain conveyed sucrose sensitiv-
ity along with kanamycin resistance, implying a single
crossover event between the intrinsic tliA and ΔtliA. In
order to induce another crossover that replaced tliA with
ΔtliA and eliminated sacB and KmR from the genome, a
single colony of the mutant strain was grown in a nonselec-
tive LB medium and spread onto a 10% sucrose LB plate. P.
fluorescens ΔtliA was selected as the colonies that grew only
on the nonselective LB plate and had no lipase activity on a
tributyrate plate.
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